Dec 13,2024
New Delhi: In the widely expanding weight loss segment in India, a medical device maker Boston Scientific, is all set to test its fortunes with the launch of Endoscopic sleeve gastroplasty (ESG) and Intragastric Balloon System (IBS) driven by Apollo and Orbera365 respectively.
The endoscopic sleeve gastroplasty (ESG) procedure is an incision-free weight loss procedure that significantly reduces stomach volume, offering a less invasive alternative to surgery for patients with obesity while Intragastric Balloon System is a silicone gastric balloon inserted into the stomach for temporarily filling it and reducing its capacity.
The launched technology Apollo ESG System is authorised by both US FDA and CDSCO whereas, Orbera365 System is indicated by CDSCO for temporary usage only and on those obese patients (BMI 30-50) who failed to achieve and maintain weight loss with a supervised weight-control program.
“With the growing incidence of obesity in India, this system provides a much-needed option for patients who may not qualify for traditional bariatric surgery but are still looking for a solution to manage their weight”, said Madan R. Krishnan, vice president and managing director, APAC Growth Markets, Boston Scientific.
Source: Healthworld